×

RNS Number : 8387T

Powerhouse Energy Group PLC

20 January 2025

 

 

20 January 2025

 

Powerhouse Energy Group Plc

("Powerhouse", "PHE" or the "Company")

 

Proposed collaboration agreement with Avioxx for the production of SAF

Powerhouse (AIM:PHE), a company pioneering integrated technology that converts non-recyclable waste into low carbon energy together with a revenue generating engineering consulting division (Engsolve), is pleased to announce that the Company has agreed to collaborate  with Avioxx Ltd (www.avioxx.com)to integrate PHE's technology for its pilot scale facility to produce 200 tonnes per annum of Sustainable Aviation Fuel ("SAF"). Avioxx, based in London and Cheshire, has developed a patented process to produce SAF from non-recyclable wastes.

Under the proposed collaboration, PHE will work with Avioxx on its pilot scale facility, Project Eden, which is expected to produce 200 tonnes per annum of SAF.  The companies are currently investigating the potential of PHE providing two 2.5 tonne per day gasification trains to supply the raw syngas to feed the facility.  The 2.5 tonne per day units are based upon the Powerhouse's Feedstock Testing Unit at the Company's Technical Centre in Bridgend.  These units will be sold to Avioxx, with a potential service agreement going forward between PHE and Avioxx.  The integration of the two companies' patented technologies is illustrated in the 3D rendering shown in the figure below.

 

 

PHE sees this as an important route to a lower carbon future and the Company's patented DMG (Distributed Modular Generation) is ideal for the smaller scale facilities and will allow its viability as a supplier of Syngas to large scale SAF facilities to be assessed.

Project Eden is still in the development phase and more information about the project and Avioxx can be found athttps://www.avioxx.co.uk/project-eden-200-TPA-modular-plant.html

Details of the Powerhouse Energy Group DMG can be found atwww.phegroup.com

 

Paul Emmitt, Chief Executive Officer of Powerhouse, commented:

"We are delighted to be collaborating with Avioxx. This is a highly significant development for the Company as it further shows the potential of our technology and its adaptability to be able to service a wide number of industries.  SAF has huge potential for us and is a sector that undoubtedly can benefit from using our technology to provide cleaner fuels for the aviation industry. 

"We look forward to working with the Avioxx team in progressing Project Eden and providing further updates in due course."

 

Chris Hancock, Chief Executive Officer of Avioxx, commented:

"Effectively harnessing the valuable molecules from waste is key to achieving a genuine circular economy and delivering economical, sustainable fuel for the aviation sector. We hope the Powerhouse technology will be the first, and most important stage of the process to transform waste to highly valuable fuel. Integration of electrochemistry allows us to dramatically improve the production efficiency of the Jet A1 kerosine. It's great to be working with Paul and the team."

 

For more information, contact:      

Powerhouse Energy Group Plc

Paul Emmitt, CEO                                                                  +44 (0) 203 368 6399

Strand Hanson Limited(Nominated & Financial Adviser)

Ritchie Balmer / James Harris / Rob Patrick                         +44 (0) 207 409 3494

SP Angel Corporate Finance LLP(Broker)

Stuart Gledhill / Adam Cowl                                                   +44 (0) 20 3470 0470

Tavistock(Financial PR)

Simon Hudson / Nick Elwes / Saskia Sizen                           +44 (0) 207 920 3150

powerhouse@tavistock.co.uk

 

About Powerhouse Energy Group Plc

Powerhouse has developed a process technology which can utilise waste plastic, end-of-life-tyres, and other waste streams to convert them efficiently and economically into syngas from which valuable products such as chemical precursors, hydrogen, electricity, heat and other industrial products may be derived. PHE's process produces low levels of safe residues and requires a small operating footprint, making it suitable for deployment at enterprise and community level.

PHE also incorporates Engsolve Ltd, which is a revenue generating business offering Engineering Services across all sectors, with speciality services in the development of new technologies and clean energy.

For more information, seewww.phegroup.com

 

About Avioxx

Avioxx is a UK-based clean energy company pioneering next-generation sustainable aviation fuel production. With a patented solid oxide fuel cell technology, Avioxx is committed to making SAF cost-competitive with traditional jet fuel, reducing aviation emissions, and securing Britain's energy independence.

For more information, see www.avioxx.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NRAQDLFFEFLZBBV

Close

×

Neville Registrars are delighted to welcome Praetura Growth VCT plc as the newest addition to its list of client companies.

Praetura Growth VCT plc have been providing market-leading investments for advisers and investors since 2011. Their team of experts from across the industry are passionate about finding the best oppportunies in EIS, VCT and BR qualifying companies. 

Further information can be found on the Company's website: www.praeturainvestments.co.uk

 

Close

×

RNS Number : 7034M

ValiRx PLC

19 November 2024

 

19 November 2024

 

ValiRx PLC

("ValiRx" or the "Company")

 

Contract Award

 

London, UK – ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women's health, provides the following contract award update from its wholly owned subsidiary Inaphaea BioLabs Limited ("Inaphaea").

Inaphaea is delighted to confirm the execution of a further contract for the provision of cell-based assays to UK biotech company, Amply Discovery Limited ("Amply"). The multiphase contract, potentially worth over £100,000 over a 8 month period, will evaluate various formulations of Amply's developmental siRNA targets in Inaphaea's Triple Negative Breast Cancer (TNBC) Patient Derived Cells (PDCs) as stand-alone agents and in combination with standard of care drugs. The deal includes an upfront payment to Inaphaea of approximately £31,000 with an additional approximately £21,000  payment on completion of the first phase after 4 months and £10,500 on completion of the remaining in-vitro phase after a further 6 weeks. Successful candidates have the option to be evaluated in-vivo using selected PDCs through one of Inaphaea's partners.

Andrew Carnegie, Head of Strategic Commercial Development at Inaphaea, commented"It is exciting to have secured this contract, which aligns our services with one of our strategic partners, and defines a good roadmap for future clients."

Mark Eccleston, CEO of ValiRx commented"This is an important contract for Inaphaea as it validates our partnered approach to offering full-service capabilities to our clients."

Dermot Tierney, COO of Amply commented"We are happy to be working with Inaphaea on this critical phase of Amply's development pathway. It was important for us to find a CRO partner who could manage the whole process with agreed milestones."

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR"). The Directors of the Company take responsibility for this announcement.

 

*** ENDS ***

 

For more information, please contact:

 

ValiRx plc   Dr Mark Eccleston, CEO	Tel: +44 (0) 2476 796496 www.valirx.com Mark.Eccleston@valirx.com
V Formation (Public Relations)   Lucy Wharton – Senior PR Executive Sue Carr – Director	+44 (0) 115 787 0206 www.vformation.biz   lucy@vformation.biz sue@vformation.biz
Cairn Financial Advisers LLP (Nominated Adviser)   Liam Murray/ Ludovico Lazzaretti	Tel: +44 (0) 20 7213 0880
Shard Capital Partners LLP (Sole Broker)   Damon Heath	Tel: +44 (0) 20 7186 9000

 

Notes for Editors

About ValiRx

ValiRx is a life science company focused on early-stage cancer therapeutics and women's health, accelerating the translation of innovative science into impactful medicines to improve patient lives.

ValiRx provides the scientific, financial, and commercial framework for enabling rapid translation of innovative science into clinical development.

Using its extensive and proven experience in research and drug development, the team at ValiRx selects and incubates promising novel drug candidates and guides them through an optimised process of development, from pre-clinical studies to clinic and investor-ready assets.

ValiRx connects diverse disciplines across scientific, technical, and commercial domains, with the aim of achieving a more streamlined, less costly, drug development process. The team works closely with carefully selected collaborators and leverages the combined expertise required for science to advance.

Lead candidates from ValiRx's portfolio are outlicensed or partnered with investors through ValiRx subsidiary companies for further clinical development and commercialisation. 

ValiRx listed on the AIM Market of the London Stock Exchange in October 2006 and trades under the ticker symbol: VAL.

For further information, visit:www.valirx.com

 

Cautionary statement

Certain statements made in this announcement are forward-looking statements. Such statements are based on current expectations and assumptions and are subject to a number of risks and uncertainties that could cause actual events or results to differ materially from any expected future events or results expressed or implied in these forward-looking statements. Persons receiving this announcement should not place undue reliance on forward-looking statements. Unless otherwise required by applicable law, regulation or accounting standard, the Company does not undertake to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

CNTXVLLFZFLFFBV

Close

×

RNS Number : 8036M

Kanabo Group PLC

19 November 2024

 

19 November 2024

Kanabo Group Plc

The GP Service Wins Award

Kanabo Group Plc ("Kanabo" or "the Company"), a leader in medical cannabis and telemedicine innovation, is pleased to announce that its subsidiary, The GP Service, has been named the winner of the Lloyds British Business Excellence Award for Tech Business of the Year. This prestigious recognition highlights The GP Service's leadership in healthcare technology, competing with some of the UK's most forward-thinking companies.

 

Strategic Growth and Innovation

Since its acquisition by Kanabo in February 2022, The GP Service has strengthened its position in the healthcare market through its robust technology platform and a network of over 6,000 pharmacies across the UK. This infrastructure facilitates secure and seamless electronic prescription delivery, demonstrating its scalability as a patient-focused solution bridging the gap between technology and accessible healthcare.

To align with its strategy of profitability and operational efficiency, The GP Service has restructured its clinical operations by outsourcing services to trusted third-party providers. This move reduces regulatory complexity while sharpening its focus on technology and scalability. This strategic shift enables The GP Service to concentrate on developing innovative solutions that enhance patient access and clinician support.

AI-Driven Expansion

The GP Service continues to refine its proprietary AI-powered Voice and Chat Bot technology, incorporating patient feedback and further testing to optimize its capabilities. Initial beta tests have shown promise. By automating patient consultations, gathering medical data, and supporting clinicians with prescription recommendations, this solution is poised to reduce administrative burdens, improve patient care, and enhance scalability.

 

Suleman Sacranie, Co-Founder of The GP Service, commented:

"This award is a powerful validation of our mission to make healthcare more accessible, efficient, and patient-focused. Competing against the UK's top technology companies, we're honored to be recognised for our innovation and impact. We look forward to continuing to redefine telemedicine and deliver value to patients and partners."

 

Ian Mattioli, Chairman of Kanabo Group Plc, added:

"The GP Service's recognition as Tech Company of the Year demonstrates its potential to set new benchmarks in healthcare innovation. While Kanabo supports its growth, The GP Service continues to chart its course as a scalable, technology-driven business delivering value to patients and partners."

 

Enquiries:

Kanabo Group plc Avihu Tamir, Chief Executive Officer Ian Mattioli, Non-Executive Chair of the Board
Peterhouse Capital Ltd (Financial Adviser)	+44 (0)20 7469 0930

 

About Kanabo Group Plc

Kanabo Group Plc is a pioneering developer of medical cannabis and telemedicine solutions. Through strategic acquisitions and innovative technologies, the company is shaping the future of global healthcare accessibility and outcomes.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NRAUKVKRSSUAARA

Close

×

RNS Number : 2653M

Marula Mining PLC

14 November 2024

 

 

 

 

 

Marula Mining PLC

("Marula'' or the "Company")

 

14 November 2024

 

Aquis Showcase 2024 Winner

 

Marula Mining (AQSE: MARUA2X: MARU) an African focused mining and development company, is pleased to announce that it was selected as the ultimate winner of the Aquis Showcase 2024 event held on 12 November 2024.

 

The Company hosted a presentation amongst two additional other companies and was voted by the audience as the winner of its own group. In total, 13 companies participated in the Aquis Showcase presentations. Marula was then selected as the final winner at the grand final following deliberation between the institutional investor panel.

 

The Directors of Marula are responsible for the contents of this announcement.

 

About Marula Mining

Marula Mining (AQSE: MARU A2X: MARU) is an African focused battery metals investment and exploration company and has interests in several high value mining operations and mine development projects in Africa: the Blesberg Lithium and Tantalum Mine, Northern Cape Lithium and Tungsten Project, Korridor Lithium Project  and Kruisrivier Cobalt Mine, all in South Africa; the Larisoro Manganese Mine and Kilifi Manganese Processing Operation both in Kenya; the Kinusi Copper Mine, the Nyorinyori Graphite Project, the NyoriGreen Graphite Project and the Bagamoyo Graphite Project all in Tanzania and the Nkombwa Hill Project in Zambia. As we advance operations at these battery metals focused projects, Marula will continue to build and expand its interests in other high-quality projects in Africa.

Marula's strategy is to identify and invest in advanced and high-value mining projects throughout East, Central and Southern Africa that the Directors believe would deliver returns for its shareholders. The Board and management team aims to establish Marula as a socially and environmentally responsible, sustainable, and profitable producer of critical metals and commodities that are of increasingly strategic importance to modern technologies and the global economy. Marula's shares are traded on AQUIS Stock Exchange (AQSE) in London and A2X Markets in South Africa. Marula is exploring opportunities to admit its shares to trading on Kenya's Nairobi Securities Exchange and South Africa's Johannesburg Stock Exchange.

 

For enquiries contact:

 

Marula Mining PLC Jason Brewer, Chief Executive Officer   Faith Kinyanjui Mumbi Investor Relations	Email : jason@marulamining.com   Email : info@marulamining.com
Broker Peterhouse Capital Limited, Charles Goodfellow / Duncan Vasey	+44 (0)20 7469 0930
Financial PR and IR BlytheRay Tim Blythe / Megan Ray / Said Izagaren	+44 (0)20 7138 3204
A2X Advisor AcaciaCap Advisors Proprietary Limited Michelle Krastanov	+27 (11) 480 8500

 

This communication is a "Reach" announcement. Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NRAFFLSULELSESF

Close

×

RNS Number : 2697L

Shearwater Group PLC

07 November 2024

 

7 November 2024

Shearwater Group PLC

 

("Shearwater", or the "Group")

 

Contract Win, G-Cloud Supplier Status Approved and Notice of Results

 

Shearwater Group plc, the cybersecurity, advisory, and managed security services group, is pleased to announce that its subsidiary, Brookcourt Solutions ("Brookcourt"), has secured a significant three-year contract with a major British media and telecommunications company. It also announces that it has achieved 'approved supplier' status with the Crown Commercial Service ("CCS"), G-Cloud 14 framework, which all public sector organisations can use to buy cloud-based computing services such as hosting, software and cloud support.

Contract win withBritish Media and Telecoms giant

Brookcourt has secured a significant three-year contract, valued at c.£3.7m. The contract will be recognised in the current financial year and contributes towards the FY25 revenue target.  It includes a comprehensive renewal of endpoint security platforms, along with advanced Data Loss Prevention (DLP) and Identity Protection solutions, reinforcing the client's security posture for years to come.

Approved supplier status with the Crown Commercial Service

Brookcourt's recognition as 'approved supplier' with the CCS is strategically significant and aligns with Shearwater's recent focus on expansion into Government departments.

Brookcourt is now able to provide a broad array of cybersecurity servicesdesigned to address the unique cybersecurity challenges faced by public sector organisations. The portfolio includes solutions enhanced by generative artificial intelligence (AI), providing buyers with powerful tools to streamline operations through automation and technological innovation.

The G-Cloud 14 framework will operate for an initial period of 18 months, extendable up to two years – doubling the term of the previous framework. Contracts awarded through this framework may run for up to four years, allowing Brookcourt to deliver sustained, high-quality cybersecurity solutions to public sector clients.

Notice of Results

The Group will provide a full update on trading together with its interim results, which will be announced on 26 November 2024.

Phil Higgins, CEO of Shearwater, commented:

"Securing approved supplier status on the Crown Commercial Service's G-Cloud 14 framework underscores our commitment to delivering innovative, high-impact cybersecurity solutions for the public sector, and demonstrates the value of the Shearwater offering.

This achievement, alongside our significant new contract with a leading British media and telecommunications company, reaffirms our dedication to empowering clients with next-generation security tools, including advanced AI-driven solutions.

We look to the future with confidence, bolstered by increased levels of customer engagement, deepened expansion into central government and a growing pipeline of opportunities."

Enquiries:

 

Shearwater Group plc David Williams, Chairman Phil Higgins, CEO Jonathan Hall, CFO	www.shearwatergroup.com c/o Alma
Cavendish Capital Markets Limited– NOMAD and Broker Adrian Hadden / Ben Jeynes / Fergus Sullivan – Corporate Finance Henry Nicol / Dale Bellis / Michael Johnson – Sales	+44 (0) 20 7220 0500
Alma Strategic Communications Justine James / Joe Pederzolli / Emma Thompson	shearwater@almastrategic.com +44 (0) 20 3405 0205

 

About Shearwater Group plc

 

Shearwater Group plc is an award-winning group providing cyber security, managed security and professional advisory solutions to create a safer online environment for organisations and their end users.

 

The Group's differentiated full service offering spans identity and access management and data security, cybersecurity solutions and managed security services, and security governance, risk and compliance. Its growth strategy is focused on building a scalable group that caters to the entire spectrum of cyber security and managed security needs, through a focused buy and build approach.

 

The Group is headquartered in the UK, serving customers globally across a broad spectrum of industries.

 

Shearwater shares are listed on the London Stock Exchange's AIM under the ticker "SWG".  For more information, please visit www.shearwatergroup.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

CNTDBBDBCDGDGSL

Close

×

RNS Number : 8080H

Trakm8 Holdings PLC

11 October 2024

 

11 October 2024

 

Trakm8 Holdings plc

("Trakm8", the "Group" or the "Company")

Contract Extension

Trakm8 Holdings plc (AIM: TRAK), the global telematics and data insight provider, is pleased to advise that the Company has been awarded a contract extension withJ Sainsbury's Information SystemsLtd ("Sainsbury's").

 

This contract extension, for two years to 31 December 2026, is for the Sainsbury's Goods Online ("GOL") delivery solution. This is built on the Trakm8 Insight AI Optimisation platform algorithms supplied via API. Since the introduction of the Sainsbury's use of Trakm8 Insight AI algorithms, over 4,000 tons of carbon have been saved each year.

 

John Watkins, Trakm8's Executive Chairman commented, "We are delighted to extend the duration of the solutions we provide to Sainsbury's having built a terrific solution together in partnership to give Sainsbury's customers the best possible experience from the GOL platform."

 

– Ends –

 

 

For further information:

Trakm8 Holdings plc
John Watkins, Executive Chairman	Tel: +44 (0) 1675 434 200
Jon Edwards, Chief Financial Officer	www.trakm8.com
Allenby Capital Limited (Nominated Adviser & Broker)	Tel: +44 (0)20 3328 5656
David Hart / Vivek Bhardwaj, Corporate Finance Tony Quirke, Sales and Corporate Broking	www.allenbycapital.com

 

 

 

 

About Trakm8

 

Trakm8 is a UK based technology leader in fleet management, insurance telematics, connected car, and optimisation. Through IP owned technology, the Group uses AI data analytics collected from its installed base of telematics units to fine tune the algorithms that are used to produce its' solutions; these monitor driver behaviour, identify crash events and monitor vehicle health to provide actionable insights to continuously improve the security and operational efficiency of both company fleets and private drivers.

 

The Group's product portfolio includes the latest data analytics and reporting portal (Trakm8 Insight), integrated telematics/cameras/optimisation, self-installed telematics units and one of the widest ranges of installed telematics devices. Trakm8 has over 275,000 connections.

 

Headquartered in Coleshill near Birmingham alongside its manufacturing facility, the Group supplies to the Fleet, Optimisation, Insurance and Automotive sectors to many well-known customers in the UK and internationally including the AA, Stark, EON, Iceland Foods, Sainsbury's, GSF, Direct Line Group, Ticker and Freedom Group.

 

Trakm8 has been listed on the AIM market of the London Stock Exchange since 2005. Trakm8 is also recognised with the LSE Green Economy Mark.

 

www.trakm8.com/ @Trakm8

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

UPDGPGBUUUPCUUG

Close

×

Neville Registrars are delighted to welcome Innovation Agritech Group Limited as the newest addition to its list of client companies.

Innovation Agritech Group build world-class aeroponic vertical farming systems using ground-breaking patented technology. Their goal is to improve the lives and businesses of the farmers, growers and entrepreneurs who use their technologies, while safeguarding the natural environment for the next generation.

Further information can be found on the Company's website: https://iagri-tech.com/ 

 

Close

×

RNS Number : 1120F

4GLOBAL PLC

23 September 2024

 

 

23 September 2024

 

4GLOBAL plc

("4GLOBAL" or "the Company")

U.S. Soccer Contract Expansion

 

4GLOBAL, a provider of data and technology for sports, fitness and wellness organisations to optimise operational and investment decisions, is pleased to announce a significant expansion of its agreement with U.S. Soccer.

 

An Insight Solutions project will see 4GLOBAL provide the data, platform and strategic insights to enable U.S. Soccer to better understand soccer facilities in theUnited States. The insights provided will be used by U.S. Soccer to inform investment and legacy planning with a view to increasing grassroots participation and growing the game of soccer nationwide.

 

The expansion builds on the initial Insight Labs project completed earlier this year, which covered a single state. The new agreement is consistent with 4GLOBAL's strategy of building long-term, iterative relationships with customers as they move through the data maturity lifecycle and uncover new opportunities to realise value from 4GLOBAL's offering.

 

With North America being a key growth market for 4GLOBAL, U.S. Soccer is an important reference customer in the region. The Company is actively targeting other sport governing bodies in the region with a similar vision while exploring opportunities elsewhere, with the model being replicable across every football association in the world.

 

Eloy Mazon, 4GLOBAL CEO, said:

 

"Having a high-profile and ambitious organisation such as U.S. Soccer keen to expand its use of 4GLOBAL's offering is testament to the value we add and the quality of the service we provide. The beauty of our model is there is no limit to the business benefits that can be derived from increased use of data, with the discovery of new opportunities to leverage it a natural part of the ongoing journey. We look forward to deepening our relationship with U.S. Soccer further and using our experience with them to expand our presence in the North American market, a key area of focus in our growth strategy.

 

Instrumental to our success in securing this expansion was our unique blend of data, technology and strategic support, coupled with our proven track record in the sector, including with the UK Department for Digital, Culture, Media and Sport; the Football Association of Ireland; and the Football Foundation.

 

It is pleasing to see that we are now taking our knowledge and expertise to new markets, enabled by the replicability of and demand for these projects overseas. This underscores our confidence in the opportunity for further international deals of this size and scale and we look forward to updating on further commercial progress in due course.".

 

Contacts

 

4GLOBAL	via Alma
Eloy Mazon (CEO)
Keith Sadler (CFO)
Spark Advisory Partners (Nominated Adviser)	+44 (0)20 3368 3554
Neil Baldwin
Canaccord Genuity (Broker)	+44 (0)20 7523 8000
Bobbie Hilliam
Alma Strategic Communications	+44 (0)20 3405 0205
Josh Royston	4global@almastrategic.com
Rebecca Sanders-Hewett
David Ison
Louisa El-Ahwal

 

About 4GLOBAL

 

4GLOBAL empowers sports, fitness and wellness organisations to make faster, smarter decisions about their operations, customers and investments through data and actionable insights.

 

It operates the largest sport participation and facility database in the world, with more than 4 billion data points.

 

Sourcing data from health & fitness operators, community programmes and other structured activities through its DataHub while drawing on information from GPS location updates and wearable devices, 4GLOBAL's unique combination of data assets provides a holistic view of physical activity patterns.  

 

4GLOBAL is at the forefront of predictive modelling and advanced analytics, with the insights it generates empowering customers to drive efficiencies, improve customer relationships and make more informed strategic decisions.

 

Its customers span both the public and private sectors, including central and local governments, cities, sporting bodies, trade associations, health & fitness operators and sports clubs.

 

Key markets include North America, the Middle East and Europe. Its headquarters are in London with offices in Miami and Istanbul.

 

4GLOBAL was founded in 2002 and listed on AIM in 2021 under the ticker 4GBL.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

CNTURVSRSVUKUAR

Close

×

RNS Number : 2324E

Kinovo PLC

16 September 2024

 

16 September 2024

 

("Kinovo", the "Group" or the "Company")

New direct award contract win of up to £12 million

 

Kinovo Plc (AIM: KINO), the specialist property services Group that delivers compliance and sustainability solutions, is pleased to announce that it has been awarded a new contract worth up to £12 million over 18 months by the London Borough of Hackney.

The contract falls under the Company's Regeneration and Renewables pillars and was awarded through the National Housing Maintenance Forum's Net Zero Carbon Framework Lot 5A, where the Company holds the top ranking for Planned Maintenance, Net Zero Carbon and Passive Safety Works.

Delivered as part of Wave 2.1 under the Social Housing Decarbonisation Fund ("SHDF"), the contract is for a range of Net Zero Carbon works including the installation of triple-glazed windows, energy efficient boilers and upgrading renewable energy systems, covering over 300 properties.

This new award is expected to mobilise in financial Q3 and replaces a contract with the London Borough of Hackney, which had been worth £6 million per annum, was out for retender in March 2024, then subsequently divided into two lots and has yet to be formally awarded to any party.

This award had been incorporated within the Company's previously disclosed three year visible revenues and thus underpins the Directors' expectations for the current financial year and contributes towards the subsequent financial year.

In addition to the above SHDF agreement, Kinovo has also been awarded a further new contract under competitive tender, with a value of up to £400,000 per annum over an initial term of 2 years, with a possible one-year extension. Involving responsive repair works to council dwellings and common areas, this will provide additional capacity to Hackney's in-house Direct Labour Organisation.

David Bullen, Chief Executive Officer of Kinovo plc, commented:

"We are delighted to continue our strong partnership with the London Borough of Hackney to deliver retrofit works and sustainable solutions. The Company continues to target driving organic growth with current and prospective partners. We remain well positioned to continue strengthening our current relationships, delivering new key contract wins and diversifying our customer base further as we continue to deliver our growth strategy."

 

Enquiries

 

Kinovo plc
Sangita Shah, Chairman David Bullen, Chief Executive Officer	+44 (0)20 7796 4133 (via Hudson Sandler)
Canaccord Genuity Limited (Nominated Adviser and Sole Broker)	+44 (0)20 7523 8000
Adam James Andrew Potts Harry Rees
Hudson Sandler (Financial PR)	+44 (0)20 7796 4133
Dan de Belder Harry Griffiths Will Reynish

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

CNTLAMLTMTJBBAI

Close